• Home
  • About Us
    • About Us
    • Leadership Team
  • Science
    • Biologics
    • Biomanufacturing
    • Pipeline
  • Investors
    • Overview
    • SEC Filings
    • Press Releases
    • Presentations
    • Corporate Governance
    • Investor Resources
      semaglutide
      • Email Alerts
      • FAQs
      • Tax Documents
  • Careers
  • Contact Us

Tivic Health Systems, Inc. Announces Pricing of Initial Public Offering

Nov 10, 2021 | Press Releases

MENLO PARK, Calif., Nov. 10, 2021 — Tivic Health Systems, Inc. (Nasdaq: TIVC) (“Tivic” or the “Company”), a commercial-phase bioelectronic medicine company, today announced the pricing of its initial public offering of 3,000,000 shares of...

Tivic Health Systems, Inc. Announces Pricing of Initial Public Offering

Nov 10, 2021 | Press Releases

MENLO PARK, Calif., Nov. 10, 2021 — Tivic Health Systems, Inc. (Nasdaq: TIVC) (“Tivic” or the “Company”), a commercial-phase bioelectronic medicine company, today announced the pricing of its initial public offering of 3,000,000 shares of...

Tivic Health’s ClearUP Device Provides Drug-free Spring Allergy Relief From Sinus Pain And Congestion With Microcurrent Waveforms

Apr 19, 2021 | Press Releases

CLEARUP’S FDA DE NOVO REQUEST GRANT BREAKS NEW GROUND WITH USE OF MICROCURRENT TO PROVIDE CONGESTION RELIEF FROM COLDS, FLU, ALLERGIESSAN FRANCISCO, April 19, 2021 — It’s spring allergy season and 50 million allergy sufferers are looking for relief...

Tivic Health’s ClearUP Device Provides Drug-free Spring Allergy Relief From Sinus Pain And Congestion With Microcurrent Waveforms

Apr 19, 2021 | Press Releases

CLEARUP’S FDA DE NOVO REQUEST GRANT BREAKS NEW GROUND WITH USE OF MICROCURRENT TO PROVIDE CONGESTION RELIEF FROM COLDS, FLU, ALLERGIESSAN FRANCISCO, April 19, 2021 — It’s spring allergy season and 50 million allergy sufferers are looking for relief...

FDA Expands Indication of Use for Tivic Health’s ClearUP Sinus Pain Relief to Include Congestion for Common Cold, Flu and Allergies

Mar 24, 2021 | Press Releases

Helping Millions Through Bioelectronics Without MedicationSAN FRANCISCO, March 24, 2021 — Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded...
« Older Entries
Next Entries »

Recent Posts

  • Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
  • Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
  • Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird’s National Security Conference
  • Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
  • Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation

Recent Comments

No comments to show.
©2026 Valion Bio

Privacy Policy

For ClearUP customer questions regarding warranty or other device inquiries, please reach out to customerservice@tivichealth.com.